Literature DB >> 9258257

Adenovirus-mediated wild-type p53 gene transfer and overexpression induces apoptosis of human glioma cells independent of endogenous p53 status.

H Li1, H Lochmüller, V W Yong, G Karpati, J Nalbantoglu.   

Abstract

Mutation or inactivation of the p53 tumor suppression gene is an early alteration in the transformation of glial cells to gliomas. To study the effect of exogenous wild-type p53 on glioma cell growth, human glioma lines U251 MG, U87 MG and A172 were infected with an adenovirus vector expressing either wild-type p53 or bacterial lacZ. Rapid cell death occurred only in the p53-transduced cell lines and was characterized by nuclear condensation, formation of nucleosomal DNA ladders, and positive in situ end-labeling of DNA, suggesting that apoptosis had been induced. The U87 MG cell line that contains wild-type p53 as evidenced by wild-type p53-dependent transcription activity also underwent apoptosis within 2 to 3 days after infection. These results suggest that the presence of endogenous wild-type p53 does not preclude apoptosis by overexpression of exogenous p53.

Entities:  

Mesh:

Year:  1997        PMID: 9258257     DOI: 10.1097/00005072-199708000-00005

Source DB:  PubMed          Journal:  J Neuropathol Exp Neurol        ISSN: 0022-3069            Impact factor:   3.685


  8 in total

1.  The clinical potential of targeted nanomedicine: delivering to cancer stem-like cells.

Authors:  Sang-Soo Kim; Antonina Rait; Farwah Rubab; Abhi K Rao; Michael C Kiritsy; Kathleen F Pirollo; Shangzi Wang; Louis M Weiner; Esther H Chang
Journal:  Mol Ther       Date:  2013-10-11       Impact factor: 11.454

Review 2.  p53 and the CNS: tumors and developmental abnormalities.

Authors:  G Fulci; E G Van Meir
Journal:  Mol Neurobiol       Date:  1999-02       Impact factor: 5.590

3.  Imaging bone morphogenetic protein 7 induced cell cycle arrest in experimental gliomas.

Authors:  Anke Klose; Yannic Waerzeggers; Parisa Monfared; Slobodan Vukicevic; Eric L Kaijzel; Alexandra Winkeler; Claudia Wickenhauser; Clemens W G M Löwik; Andreas H Jacobs
Journal:  Neoplasia       Date:  2011-03       Impact factor: 5.715

4.  Splicing factor SRSF1 promotes gliomagenesis via oncogenic splice-switching of MYO1B.

Authors:  Xuexia Zhou; Run Wang; Xuebing Li; Lin Yu; Dan Hua; Cuiyun Sun; Cuijuan Shi; Wenjun Luo; Chun Rao; Zhendong Jiang; Ying Feng; Qian Wang; Shizhu Yu
Journal:  J Clin Invest       Date:  2019-01-14       Impact factor: 14.808

5.  Exogenous wt-p53 enhances the antitumor effect of HSV-TK/GCV on C6 glioma cells.

Authors:  Qiang Huang; Peiyu Pu; Zhibo Xia; Yongping You
Journal:  J Neurooncol       Date:  2006-11-11       Impact factor: 4.506

6.  Novel Perspectives on p53 Function in Neural Stem Cells and Brain Tumors.

Authors:  Sanna-Maria Hede; Inga Nazarenko; Monica Nistér; Mikael S Lindström
Journal:  J Oncol       Date:  2010-12-15       Impact factor: 4.375

7.  Temozolomide induces apoptosis and senescence in glioma cells cultured as multicellular spheroids.

Authors:  W Günther; E Pawlak; R Damasceno; H Arnold; A J Terzis
Journal:  Br J Cancer       Date:  2003-02-10       Impact factor: 7.640

Review 8.  Gene therapy for malignant glioma.

Authors:  Hidehiro Okura; Christian A Smith; James T Rutka
Journal:  Mol Cell Ther       Date:  2014-07-08
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.